Enrique Conterno
2021
Compensation breakdown
| Non-Equity Incentive Plan | $422,297 |
|---|---|
| Option Awards | $4,732,876 |
| Salary | $825,000 |
| Stock Awards | $4,346,820 |
| Other | $58,110 |
| Total | $10,385,103 |
Conterno received $4.7M in option awards, accounting for 46% of the total pay in 2021.
Conterno also received $422.3K in non-equity incentive plan, $825K in salary, $4.3M in stock awards and $58.1K in other compensation.
Rankings
In 2021, Enrique Conterno's compensation ranked 983rd out of 12,415 executives tracked by ExecPay. In other words, Conterno earned more than 92.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 983 out of 12,415 | 92nd |
Division Manufacturing | 330 out of 5,501 | 94th |
Major group Chemicals And Allied Products | 110 out of 2,374 | 95th |
Industry group Drugs | 93 out of 2,095 | 96th |
Industry Pharmaceutical Preparations | 61 out of 1,542 | 96th |
Pay ratio
| Enrique Conterno's Pay | $10,385,103 |
|---|---|
| Median Employee's Pay | $174,414 |
| Pay Ratio | 60to 1 |
In 2021, the annual total compensation of Enrique Conterno was $10,385,103.
The annual total compensation of the median employee at FibroGen was $174,414.
The ratio of Enrique Conterno's pay to the pay of median employee was therefore 60 to one.
Conterno's colleagues
We found six more compensation records of executives who worked with Enrique Conterno at FibroGen in 2021.
2021
Christine Chung
FibroGen
Senior Vice President, China Operations
2021
Mark Eisner
FibroGen
Chief Medical Officer
2021
Pat Cotroneo
FibroGen
Chief Financial Officer
2021
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2021
Thane Wettig
FibroGen
Chief Commercial Officer
2021
Juan Graham
FibroGen